Studies

CellWell record HH-574472

The predictive role of estrogen, FSH, and LH in combination with biomarkers for early ovarian cancer detection

Bayadir Abdul Hussein Mahameed; Hadel Kareem Al-Rubaiawi; Maha H. Ahmed; Osama A. Mohsein

Mìžnarodnij Endokrinologìčnij Žurnal · 2026

In plain language

Low estrogen and high FSH and LH, together with elevated CA-125 and HE4, were linked to early-stage ovarian cancer, and combining hormones with tumor markers gave the best diagnostic accuracy (AUC 0.94).

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on DOI

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-574472

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.